Thursday 16 January 2014 19.26 <\/p>\n
Pioneering gene therapy has restored vision to two men with a rare inherited eye disease who were told to expect to go blind. <\/p>\n
Scientists hope early intervention with the surgical treatment will halt progression of the devastating disorder, choroideremia, before patients are robbed of their sight. <\/p>\n
It is the first time gene therapy has successfully been applied to the light-sensitive photoreceptors of the retina, the digital camera at the back of the eye. <\/p>\n
Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team. <\/p>\n
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight. <\/p>\n
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness. <\/p>\n
Professor Robert MacLaren, who led the gene therapy operations at Oxford Eye Hospital, said: \"We're absolutely delighted with the results so far. <\/p>\n
\"It is still too early to know if the gene therapy treatment will last indefinitely, but we can say that the vision improvements have been maintained for as long as we have been following up the patients, which is two years in one case. <\/p>\n
\"In truth, we did not expect to see such dramatic improvements in visual acuity and so we contacted both patients' home opticians to get current and historical data on their vision in former years, long before the gene therapy trial started. <\/p>\n
<\/p>\n
Excerpt from:<\/p>\n
Gene therapy breakthrough in blindness research<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Thursday 16 January 2014 19.26 Pioneering gene therapy has restored vision to two men with a rare inherited eye disease who were told to expect to go blind. Continue reading